
|Videos|October 5, 2017
Addressing Issues Surrounding Current Antibiotic Development
Author(s)Contagion® Editorial Staff
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
Advertisement
James S. Lewis, PharmD, FIDSA, Co-Director of Antibiotic Stewardship, Oregon Health and Science University, addresses the issues that surround current antibiotic development. The primary issue involves a common perception shared by some pharmaceutical companies regarding return on investment.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Advertisement
Advertisement

































































































































































































































































































